Health October 09, 2026

Building an effective drug diversion prevention committee

Key Takeaways

  • Effective drug diversion prevention requires multidisciplinary collaboration across pharmacy, nursing, compliance, security, and IT, not just pharmacy alone.
  • Gap analyses, Gemba walks, and benchmarking resources help teams align frontline workflows with policies and strengthen oversight.
  • Technology like Sentri7 Drug Diversion aggregates data across systems, easing staffing constraints and enabling standardized, proactive monitoring enterprise-wide.

Drug diversion remains one of healthcare's most persistent and complex challenges. Industry data suggests that approximately 10% of healthcare workers experience substance use disorder, and about 1 in 100 actively divert medications. Combined with workforce shortages, evolving diversion tactics, and increasing regulatory scrutiny, healthcare organizations face growing pressure to strengthen their diversion prevention efforts. 

While no single strategy can eliminate diversion risk, healthcare leaders are finding success by focusing on two critical drivers of program effectiveness: multidisciplinary collaboration and technology. Together, these elements help organizations move from reactive investigations to proactive prevention. 

Drug diversion prevention requires a team approach 

Successful diversion prevention programs recognize that drug diversion is not solely a pharmacy issue. It is an organizational responsibility that requires collaboration across multiple departments. 

Many healthcare organizations establish multidisciplinary diversion committees that bring together pharmacy, nursing, compliance, security, human resources, information technology, and executive leadership. Each stakeholder contributes a unique perspective, helping organizations identify risks, improve processes, and respond appropriately when concerns arise. 

Regular committee meetings create opportunities to share insights, review trends, discuss investigations, and strengthen accountability across the organization. They also help ensure diversion prevention remains visible at all levels of the health system. 

Organizations with strong multidisciplinary engagement are often better positioned to identify vulnerabilities, align policies, and drive meaningful improvements across care settings.

Multidisciplinary drug diversion teams enhances oversight 

Collaboration is most effective when teams understand how frontline practices align with established policies and procedures. 

One approach highlighted by diversion leaders is conducting comprehensive gap analyses and Gemba walks, allowing organizations to observe medication-use workflows where work is performed. These assessments can identify process breakdowns, operational challenges, and opportunities for improvement that may not be visible through reports alone. 

Resources such as American Society of Health-System Pharmacists guidelines on preventing diversion of controlled substances and the Minnesota Hospital Association Road Map to Controlled Substance Diversion Prevention can help organizations benchmark current practices and prioritize improvements. 

By engaging directly with frontline staff and understanding the realities of daily workflows, multidisciplinary teams can develop practical solutions that strengthen both compliance and patient safety. 

Staffing challenges make collaboration more important than ever 

A widely recognized and ongoing challenge, the U.S. healthcare worker shortage is expected to reach 100,000 by 2028, from nursing to pharmacy and IT. Successful drug diversion detection programs often require the involvement of stakeholders across these care teams; as a result, health systems struggle to allocate enough full-time equivalents (FTEs) dedicated to drug diversion efforts. With healthcare professionals spread thin across many functions and departments, it can be difficult to allocate the resources necessary for drug diversion education and prevention efforts, as well as thoroughly conduct investigations within a healthcare system. 

Many organizations initially have only one dedicated FTE for diversion prevention, necessitating prioritization of drug diversion monitoring tasks. For program leaders seeking additional resources, committee structures can also help demonstrate organizational need. By collecting and sharing data related to investigations, workload demands, and key performance indicators, teams can build a stronger business case for program investment and expansion. Supported by data and hard evidence, increased personnel allow for more focused efforts on compliance and monitoring.  

Multidisciplinary teams help distribute responsibilities and ensure critical expertise is available when diversion concerns arise. They also provide a framework for sharing workload, improving communication, and maintaining program continuity despite staffing constraints. 

Drug diversion technology helps teams work more efficiently 

Even the most engaged diversion committee can struggle without the right tools. 

Many organizations continue to rely on manual processes that require staff to pull information from multiple systems, compare records, and assemble data for investigations. These activities can be time-consuming and may delay the identification of diversion risks. 

To alleviate the manual burden on the drug diversion prevention team, many organizations turn to Sentri7 Drug Diversion, which aggregates data from various sources, including automated dispensing cabinets (ADC) and electronic medical records (EMR). 

The technology enables a high-level review of team members who may be at risk for diversion, streamlining the investigation process. 

To stay ahead of evolving diversion methods, it’s crucial to invest in advanced tools that integrate information from multiple IT sources and are regularly updated and improved. Enhancing technological infrastructure not only eases the reporting burden on hospital staff but also ensures health systems remain agile and effective in preventing drug diversion. 

Rather than replacing human expertise, technology allows multidisciplinary teams to spend less time gathering information and more time evaluating, investigating, and acting on insights.

A unified approach strengthens diversion prevention 

As healthcare systems expand across multiple facilities, maintaining consistent diversion prevention practices becomes increasingly challenging. 

Different sites often have unique workflows, staffing models, and operational processes. Without centralized oversight, gaps in monitoring and compliance can emerge. 

Technology enables organizations to standardize monitoring, reporting, and investigation processes across the enterprise. Aggregated data provides greater visibility into trends and potential risks, while automated reporting reduces administrative burden and supports more consistent decision-making. 

When combined with multidisciplinary governance, technology creates a framework that helps organizations establish best practices and maintain oversight across diverse care settings.

Bolster your drug diversion prevention committee with proven strategies 

The most effective drug diversion programs recognize that people and technology are not competing solutions. They are complementary strengths. 

Multidisciplinary teams provide the expertise, collaboration, and accountability necessary to drive organizational change. Technology provides the visibility, efficiency, and scalability needed to identify and address diversion risks in an increasingly complex healthcare environment. 

Together, these capabilities help healthcare organizations move beyond reactive investigations and develop proactive diversion-prevention programs that support patient safety, regulatory compliance, and staff well-being. 

See how resilient drug diversion programs are built 

As diversion challenges continue to evolve, organizations that invest in both strong multidisciplinary partnerships and technology-enabled surveillance will be best positioned to build resilient programs that protect patients, support caregivers, and reduce diversion risk across the continuum of care. 

Watch the on-demand webinar, From Risk to Resilience, Drug Diversion Programs in Action, for more best practices for establishing a drug diversion prevention program. 

Watch the Webinar

From Risk to Resilience_ Drug Diversion Programs in Action.png
From Risk to Resilience: Drug Diversion Programs in Action
Gordon Watkins
Specialized Consulting Manager
Dr. Gordon Watkins has over 8 years of experience in institutional pharmacy clinical practice and operations, most specifically in implementing and optimizing pharmacy technology solutions.
Back To Top